Isis Pharmaceuticals (ISIS)

Add to Watchlists
Create an Alert
65.09 +5.54  +9.30% NASDAQ Dec 19, 8:00PM BATS Real time Currency in USD
View Full Chart
ISIS Price Chart
View All Events

ISIS Events

Date Type Description
11/07/2014 08:30 PST Misc Q3 2014 Isis Pharmaceuticals Earnings Conference Call
11/07/2014 Earnings Q3 2014 Isis Pharmaceuticals Earnings Results
08/04/2014 10:30 EDT Misc Q2 2014 Isis Pharmaceuticals Earnings Conferecec Call
08/04/2014 Earnings Q2 2014 Isis Pharmaceuticals Earnings Results
05/06/2014 11:30 EDT Misc Isis Pharmaceuticals 1Q2014 Earning Conference Call
05/06/2014 Earnings Isis Pharmaceuticals 1Q2014 Earning Result
02/28/2014 11:30 EDT Misc Isis Pharmaceuticals Q4 2013 Earning Conference Call
02/28/2014 Earnings Isis Pharmaceuticals Q4 2013 Earning Result
View All Performance Charts

ISIS Total Returns Comparison

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Isis Pharmaceuticals is up 67.20% over the last year vs S&P 500 Total Return up 16.79%, Regeneron Pharmaceuticals up 58.06%, and Biomarin Pharmaceutical up 37.27%.

Get Quote for

PDF Report for ISIS

Download Ratings, Key Stats, Performance Charts, Valuations, and Financials in an easy to print format.

Download ISIS Pro Report PDF
Advertisement

Portfolio Strategies Featuring ISIS

Did Isis Pharmaceuticals make it into our Portfolio Strategies?
Start your YCharts membership now to find out.

ISIS Profile

  • Sector: Healthcare
  • Industry: Biotechnology
  • Company Website: http://www.isispharm.com
  • IR Website: http://ir.isispharm.com/phoenix.zhtml?c=222170&p=irol-irhome
  • HQ Country: United States
  • HQ State/Province: California
  • Incorporation Country: United States
  • Incorporation State/Province: Delaware
  • Est. Current Fiscal Quarter End: December 31, 2014
  • Est. Current Fiscal Year End: December 31, 2014
  • Last Fiscal Quarter End: September 30, 2014
  • Last Fiscal Year End: December 31, 2013
  • Next Earnings Release: N/A
  • NAICS: Pharmaceutical Preparation Manufacturing
  • NAICS Code: 325412
  • NAICS Industry: Pharmaceutical and Medicine Manufacturing
  • NAICS Sector: Manufacturing

Isis Pharmaceuticals is engaged in antisense drug discovery and development, exploiting a novel drug discovery platform it created to generate a broad pipeline of first-in-class drugs.

ISIS Excel Add-In Codes

  • Name: =YCI("ISIS","name")
  • Description: =YCI("ISIS","description")
  • Sector: =YCI("ISIS","sector")
  • Industry: =YCI("ISIS","industry")
  • Est. Current Fiscal Year End: =YCI("ISIS","fye")

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

You've hit the 10 page limit on YCharts.

Experience the power of YCharts.
Start your Free 14-Day Trial.

Start My Free Trial No credit card required.

Already a subscriber? Sign in.

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}
Start your free 14 Day Trial.

{{root.upsell.info.button_text}} No credit card required.

Already a subscriber? Sign in.